Integrator complex subunit 12 (329-345)

Integrator complex subunit 12 (329-345) is a synthetic peptide fragment derived from the human Integrator complex subunit 12 (INTS12) protein, corresponding to amino acids 329 through 345. As part of the larger Integrator complex, INTS12 plays a crucial role in the regulation of RNA polymerase II-mediated transcription and RNA processing, particularly in the 3′-end processing of small nuclear RNAs (snRNAs). The 329-345 peptide region is of particular interest for dissecting the structure-function relationships within the Integrator complex, facilitating studies into protein-protein interactions, post-translational modifications, and the molecular mechanisms governing RNA metabolism. Researchers utilize this peptide as a valuable biochemical tool to probe the specific contributions of the INTS12 C-terminal domain in cellular regulatory processes.

Peptide mapping and epitope characterization: The 329-345 segment of INTS12 serves as a well-defined epitope for generating and validating antibodies specific to the C-terminal region of the protein. By employing this synthetic peptide in immunization protocols or as a standard in immunoassays, researchers can develop highly selective antibodies that enable precise detection and quantification of INTS12 in cell lysates, tissue extracts, or purified complexes. Such antibodies are instrumental for Western blotting, immunoprecipitation, and immunofluorescence studies, thereby advancing the understanding of Integrator complex localization and dynamics.

Protein-protein interaction studies: The synthetic INTS12 (329-345) peptide is frequently used in in vitro binding assays to elucidate the interaction surfaces between INTS12 and its molecular partners within the Integrator complex or with associated regulatory proteins. By incorporating this peptide into pull-down assays, surface plasmon resonance (SPR), or isothermal titration calorimetry (ITC) experiments, researchers can map binding interfaces, determine affinity constants, and identify critical residues involved in complex assembly. Such insights are essential for unraveling the mechanistic basis of Integrator-mediated RNA processing.

Post-translational modification analysis: The defined sequence of the INTS12 (329-345) peptide provides a controlled substrate for investigating potential post-translational modifications, such as phosphorylation, methylation, or ubiquitination, that may occur within this region. Using mass spectrometry-based approaches or enzyme assays, scientists can assess modification patterns, enzyme specificity, and the functional consequences of such modifications on Integrator complex activity. These studies contribute to a deeper understanding of regulatory pathways that modulate gene expression at the RNA processing level.

Structural biology and conformational studies: As a chemically defined fragment, the peptide corresponding to INTS12 (329-345) is suitable for structural analyses using techniques such as nuclear magnetic resonance (NMR) spectroscopy or X-ray crystallography. By studying the isolated peptide or its complexes with binding partners, researchers can gain atomic-level insights into secondary structure propensities, conformational flexibility, and interaction motifs. This information aids in constructing accurate models of the Integrator complex and informs rational design of functional mutants or modulators.

Peptide-based assay development: The INTS12 (329-345) peptide is also utilized in the development of quantitative and qualitative assays for screening small molecules or proteins that interact with the Integrator complex. By immobilizing the peptide on assay platforms or incorporating it into competitive binding formats, scientists can identify inhibitors, modulators, or novel interactors that influence Integrator function. These assays support high-throughput screening efforts and facilitate the discovery of chemical probes for dissecting RNA processing pathways in eukaryotic systems.

1. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

2. Cationic cell-penetrating peptides are potent furin inhibitors

3. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs

4. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

5. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines